Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shirin Milani"'
Autor:
Shirin Milani, Bob Djavan
Publikováno v:
BJU International. 95:29-36
An update of a systematic review of alpha1-adrenoceptor (AR) antagonists in the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) showed that these agents have comparable efficacy. The total symptom score
Publikováno v:
European Urology Supplements. 4:61-68
Objectives: This randomised, double-blind, placebo-controlled, 8-week exploratory study was designed to assess the effect of the new formulation of tamsulosin (oral controlled absorption system: OCAS) on nocturia, the hours of undisturbed sleep and q
Autor:
Fariborz Bagheri, Shirin Milani, Matthias Waldert, Bob Djavan, Yan Kit Fong, Aziz Chaudry, Theodore Anagnostou, Mike Harik, Harun Fajkovic, Andreas Reissigl, Sören Kreuzer, Michael Marberger
Publikováno v:
Urology. 64:1144-1148
Objectives To determine the risk of clinical progressions in men with mild lower urinary tract symptoms of bladder outlet obstruction and identify the predictors for progression in this group of men. Methods A total of 397 men who presented to the ur
Publikováno v:
The Canadian journal of urology. 12
Biochemical parameters and pathological features as well as biopsy related morbidity of prostate cancer detected on second, third and fourth repeat prostate biopsy in men with a serum total PSA level between 4 ng/mL and 10 ng/mL were evaluated and co
Publikováno v:
Expert opinion on pharmacotherapy. 6(2)
Dutasteride is a new dual 5alpha-reductase inhibitor for the treatment of benign prostatic hyperplasia. It differs from finasteride as it inhibits both isoenzymes of 5alpha-reductase and results in near-complete suppression of serum dihydro-testoster
Publikováno v:
Current opinion in urology. 15(1)
Serenoa repens extract is a popular phytotherapeutic agent in men with lower urinary tract symptoms. Although the exact mechanism of action is unknown, the agent is generally well accepted for its easy availability and good tolerability. This paper r
Publikováno v:
Current opinion in urology. 15(1)
Purpose of review Prevalence of benign prostatic hyperplasia (BPH) is increasing with the aging population worldwide. Knowledge of the natural history of BPH is crucial for primary, secondary and tertiary prevention of its progression. This review ex
Publikováno v:
Urology. 65(2)
d a s p c t m n ositive cancer margins occur in 11% to 46% of patients after radical prostatectomy. It is genrally agreed that the presence of positive margins s a poor prognostic sign, with biochemical or clincal recurrence noted in as many as 63% o
Publikováno v:
Urology. 64(6)